Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Asian Market Preview: Nikkei Futures +1.37%, Hang Seng Futures (0.07%), ASX SPI 200 +0.99%, S&P Futures +0.98%

Nov 19 ,2025

  • Synopsis:

    • Asian markets set for positive start to Thursday trade. Futures signaling opening gains in Japan, with Australia also trading higher in initial trade. Hong Kong tracking for flat start. US contracts strengthening afterhours with NVDA +5% following earnings. Australian bonds weakening after Treasury yields reversed higher overnight. Dollar weakening against Aussie, steady against majors after straightening to mid-Jan highs against yen. Crude drifting up from earlier lows while gold flat. Bitcoin continues to hover around $90K.

    • NVDA delivered another beat and raise. Reiterated expectations for $500B in Blackwell and Rubin revenue through 2026, with potential to exceed that total. Did not make any H20 sales in China due to Beijing restrictions, and Q4 guidance assumes no China contribution. Touched on rising input costs (memory) but still aiming to keep GMs in mid-70s. Downplayed bubble concerns, pointing to AI proliferation. Addressed circularity concerns by pointing to growth potential of OpenAI and Anthropic.

    • China expected to keep 1Y and 5Y loan prime rates unchanged after PBOC left 7D reverse repo on hold earlier this month. Monetary easing expectations have receded recently after PBOC rhetoric shifted in a more neutral direction. Takeaways from broadly weak October activity data noted data still left government on track to achieve annual growth target of ~5%, reducing urgency for fresh measures. Economic support also expected from fiscal measures announced in September intended to boost investment.

    • In developments late Wednesday, BOJ Governor Ueda met Japan government ministers though no specific discussions about FX while Finance Minister Katayama said no objection to BOJ policy stance. Meeting occurred against backdrop of weakening yen and backup in JGB yields as government's stimulus push heightens concerns about fiscal risks. Latest reports noted government looking to compile package worth more than JPY20T, larger than had been mentioned before in press.

  • Pre-open Company News:

    • FLX -- BingEx reports Q3 non-GAAP net income CNY62.6M vs year-ago CNY20.4M

    • 2586.HK -- Dmall inc. to launch share repurchase plan under existing mandate

    • 500660.IN -- GlaxoSmithKline Pharmaceuticals CFO Juby Chandy to take up new role within GSK Group, effective 1-Dec

    • 544574.IN -- Tata Capital initiated overweight at JPMorgan

    • 600521.CH -- Zhejiang Huahai Pharmaceutical's HB0017 hits all primary and key secondary endpoints in China phase III for plaque psoriasis

    • 272.HK -- Shui On Land forms JV for urban renewal project in Shanghai Pudong

    • 532532.IN -- Adani Enterprises receives LoI from resolution professional for acquiring Jaiprakash Associates

    • 601136.CH -- Capital Securities chairman Bi Jinsong retires, effective immediately

    • 2556.HK -- Marketingforce Management reports Q3 AI+SaaS business revenue +45% y/y

    • DDRIL.NO -- Dolphin Drilling announces Oil India exercises option to extend drilling contract with deepwater capable semisubmersible rig Blackford Dolphin

    • S68.SP -- Singapore Exchange announces partnership with Nasdaq to simplify dual listings

    • 3908.HK -- CICC to absorb Dongxing Securities and Cinda Securities via A-share swap merger; shares suspended from 20-Nov

  • On Deck:

    • China:

      • Economic:

        • 08:00 CST: Foreign Direct Investment Y/Y; consensus

        • 09:30 CST: 5 Year Loan Prime Rate; consensus

        • 09:30 CST: 1 Year Loan Prime Rate; consensus

    • Hong Kong:

      • Earnings:

        • Biocytogen Pharmaceuticals (2315.HK), Lenovo Group (992.HK), CSPC Pharmaceutical Group (1093.HK), Alliance International Education Leasing Holdings (1563.HK), Link REIT (823.HK)

    • Australia:

      • Earnings:

        • WEB Travel Group (WEB.AU)

    • New Zealand:

      • Earnings:

        • Eroad (ERD.NZ), Oceania Healthcare (OCA.NZ)

  • Market Data:

    • Gold (Dec 25): +$4.80 or +0.12% to $4087.60

    • WTI Crude (Dec 25): +$0.22 or +0.37% to $59.66

    • $-¥: +1.55 or +1.00% to 157.0650

    • $-KRW: +6.85 or +0.47% to 1466.2300

    • A$-$: (0.00) or (0.28%) to 0.6490

    • $-INR: (0.06) or (0.07%) to 88.4869

    • $-CNY: +0.00 or +0.04% to 7.1106

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE